Key facts
- Medsense Health’s last known valuation is $5.5M (Dec 2022).
- It has raised $5.5M across 2 recorded rounds; the latest was Seed Round ($4.0M) in Jan 2024.
- Notable investors include HealthX Ventures, Blue Cross and Blue Shield of Illinois.
- Medsense Health has filed 4 Form Ds with the SEC since 2022, most recently Oct 2025 ($4.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Medsense Health
Funding rounds
2 roundsAbout Medsense Health
Developer of a technology, process, and clinical staff designed to deploy revenue-generating medication adherence programs. The company's application provides Bluetooth sensors that attach to medication containers, a medication adherence monitoring engine, a front-end application for patients and providers, and an integration application programming interface for developers, enabling patients to track the intake of an unlimited range of medications, regardless of the schedule and dosage.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2019
- Employees
- 10
- Website
- medsense.health/
- Ownership
- Privately Held (backing)
Medsense Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medsense Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medsense Health in its N-PORT filings yet. We sweep new filings monthly.